Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival
Impact in
- Immunology 3.2k
- Oncology 2.1k
Classified as
- Journal
- Nature Medicine
In The Last Decade
doi.org/10.1038/nm1093 →Countries where authors are citing Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival
This map shows the geographic impact of Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival more than expected).
Fields of papers citing Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival
This network shows the impact of Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival.
About Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival
This paper, published in 2004, received 4.4k indexed citations . Written by Tyler Jay Curiel, George Coukos, Linhua Zou, Xavier A. Alvarez, Pui Joan Cheng, Peter J. Mottram, Jose Ramon Conejo-Garcia, Lin Zhang, Matthew E. Burow and Yun Zhu covering the research area of Immunology. It is primarily cited by scholars working on Immunology (3.2k citations), Oncology (2.1k citations), Molecular Biology (551 citations), Cancer Research (207 citations) and Reproductive Medicine (162 citations). Published in Nature Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
This paper is also available at doi.org/10.1038/nm1093.